Liang Yu
- Epidemiology
- Infectious Diseases top 10%
- Molecular Biology
- Neurology top 10%
- Genetics top 10%
- Topics
- Influenza Virus Research Studies (6 papers)Liver Disease Diagnosis and Treatment (5 papers)Hepatitis C virus research (5 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Liang Yu
31 papers receiving 684 citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Epidemiology 217
- Infectious Diseases 213
- Molecular Biology 139
- Neurology 114
- Genetics 110
Countries citing papers authored by Liang Yu
This map shows the geographic impact of Liang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Yu more than expected).
Fields of papers citing papers by Liang Yu
This network shows the impact of papers produced by Liang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Yu. The network helps show where Liang Yu may publish in the future.
Co-authorship network of co-authors of Liang Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Liang Yu. A scholar is included among the top collaborators of Liang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang Yu. Liang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Correlation between atherogenic index of plasma and cardiovascular disease risk across Cardiovascular–kidney–metabolic syndrome stages 0–3: a nationwide prospective cohort studybreakdown → | 20 |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 9 | |
| 5 | 58 | |
| 6 | 38 | |
| 7 | Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A (H7N9) Infection: A Hint for COVID-19 Treatmentbreakdown → | 195 |
| 8 | 7 | |
| 9 | 1 | |
| 10 | 0 | |
| 11 | 17 | |
| 12 | 25 | |
| 13 | 13 | |
| 14 | 9 | |
| 15 | 64 | |
| 16 | 5 | |
| 17 | 10 | |
| 18 | 7 | |
| 19 | 11 | |
| 20 | 8 |
About Liang Yu
Liang Yu is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 33 papers that have together received 701 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis C virus research (5 papers). The work is most often cited by research in Hepatology (97 citations), Infectious Diseases (213 citations) and Genetics (110 citations). Liang Yu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Lanjuan Li, Hainv Gao, Lingling Tang, Lijun Chen, Xiaoqing Lu, Xiaowei Xu, Xiahong Dai, Jiajia Chen, Lü Chen and Yixin Zhu. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases and Human Molecular Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.